Loading provider…
Loading provider…
Retina Specialist (Ophthalmology) Physician in Los Angeles, CA
NPI: 1124298575Primary Practice Location
Hollywood Presbyterian Medical Center
1300 N Vermont Ave, Los Angeles, CA
Primary Employer
Cha Medical and Surgical Group, PC
hpmedcenter.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2006 - 2025

American Board of Ophthalmology
Ophthalmology
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 2003
University of Southern California/LAC+USC Medical Center
Fellowship • Surgical Retina and Vitreous
2008 - 2010
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Ophthalmology
2005 - 2008
Cedars-Sinai Medical Center
Internship • Internal Medicine
2003 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 947 | 3,503 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 626 | 1,119 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 571 | 1,167 |
| 4 | 92201Extended examination of eye with drawing of retina | 345 | 423 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 295 | 295 |
Conjunctival epithelium in pars plana vitrectomy specimens.
Authors: Thomas Albini, Lawrence Chong, Narsing Rao
Journal: Retina
Ophthalmic manifestations of immune reconstitution inflammatory syndrome associated with Cryptococcus neoformans.
Authors: Khurana RN Javaheri M Rao N
Phenotypic Spectrum of Benign Lobular Inner Nuclear Layer Proliferations: A Multicenter Analysis and Review of the Literature.
Authors: Christian Sanfilippo, Jesse Berry, Chris Bergstrom, Aaron Nagiel
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Aflibercept 8 mg